Header Logo

Connection

Summer Dewdney to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Summer Dewdney has written about Clinical Trials, Phase II as Topic.
Summer Dewdney
Connection Strength
0.047
Clinical Trials, Phase II as Topic
  1. Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study. Gynecol Oncol. 2021 04; 161(1):113-121.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.